Skip to search formSkip to main contentSkip to account menu

Wolchok Solid Tumors 2009 Oncology Response Criteria

Known as: WOLCHOK SOLID TUMORS 2009 
Guidelines for the Evaluation of Immune Therapy Activity in Solid Tumors: Immune-Related Response Criteria. (Wolchok JD, Hoos A, O'Day S, Weber JS… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2019
Review
2019
2018
2018
n engl j med 379;22 nejm.org November 29, 2018 2178 2. Kiess AP, Wolchok JD, Barker CA, et al. Stereotactic radio­ surgery for… 
Review
2017
Review
2017
Opinion statementBrain metastases are a major clinical challenge occurring in up to 60% of patients suffering from metastatic… 
Review
2016
Review
2016
In recent years, an increased understanding of T‐cell–regulatory mechanisms has led to the development of a novel class of immune… 
Highly Cited
2015
Highly Cited
2015
Treatment of extensively drug-resistant mycobacteria tuberculosis is a growing global challenge. In this report, the durability… 
2015
2015
475 m/s n° 5, vol. 31, mai 2015 DOI : 10.1051/medsci/20153105005 6. Ziogas AC, Gavalas NG, Tsiatas M, et al. VEGF directly… 
Review
2014
Review
2014
ABSTRACT Aim: The immune related response criteria were published in November 2009, based on results and clinical findings of the… 
2013
2013
  • M. Razzak
  • Nature Reviews Clinical Oncology
  • 2013
  • Corpus ID: 35518667
From ASCO—targeted therapies: Anti-PD-1 approaches—important steps forward in metastatic melanoma 
2011
2011
  • M. Brown
  • Immunotherapy
  • 2011
  • Corpus ID: 19813558
Evaluation of: Wolchok JD, Weber JS, Hamid O et al.: Ipilimumab efficacy and safety in patients with advanced melanoma: a…